These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 16793161

  • 1. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
    Pai Kasturi S, Qin H, Thomson KS, El-Bereir S, Cha SC, Neelapu S, Kwak LW, Roy K.
    J Control Release; 2006 Jul 20; 113(3):261-70. PubMed ID: 16793161
    [Abstract] [Full Text] [Related]

  • 2. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines.
    Kasturi SP, Sachaphibulkij K, Roy K.
    Biomaterials; 2005 Nov 20; 26(32):6375-85. PubMed ID: 15913771
    [Abstract] [Full Text] [Related]

  • 3. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
    Biragyn A, Tani K, Grimm MC, Weeks S, Kwak LW.
    Nat Biotechnol; 1999 Mar 20; 17(3):253-8. PubMed ID: 10096292
    [Abstract] [Full Text] [Related]

  • 4. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
    Oster CG, Kim N, Grode L, Barbu-Tudoran L, Schaper AK, Kaufmann SH, Kissel T.
    J Control Release; 2005 May 18; 104(2):359-77. PubMed ID: 15907586
    [Abstract] [Full Text] [Related]

  • 5. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M, Ria F, Parrella P, Signori E, Serra A, Ciafrè SA, Vespignani I, Lazzari M, Farace MG, Saglio G, Fazio VM.
    Cancer Res; 2001 Feb 15; 61(4):1555-62. PubMed ID: 11245465
    [Abstract] [Full Text] [Related]

  • 6. Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model.
    Rinaldi M, Fioretti D, Iurescia S, Signori E, Pierimarchi P, Seripa D, Tonon G, Fazio VM.
    Biochem Biophys Res Commun; 2008 May 30; 370(2):279-84. PubMed ID: 18364239
    [Abstract] [Full Text] [Related]

  • 7. Microparticle-mediated gene delivery for the enhanced expression of a 19-kDa fragment of merozoite surface protein 1 of Plasmodium falciparum.
    Liu S, Danquah MK, Forde GM, Ma C, Wang L, Coppel R.
    Biotechnol Prog; 2010 May 30; 26(1):257-62. PubMed ID: 19924768
    [Abstract] [Full Text] [Related]

  • 8. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
    Ruffini PA, Neelapu SS, Kwak LW, Biragyn A.
    Haematologica; 2002 Sep 30; 87(9):989-1001. PubMed ID: 12217812
    [Abstract] [Full Text] [Related]

  • 9. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
    Fredriksen AB, Sandlie I, Bogen B.
    Mol Ther; 2006 Apr 30; 13(4):776-85. PubMed ID: 16414309
    [Abstract] [Full Text] [Related]

  • 10. [Construction of a DNA vaccine against human B cell lymphoma].
    Zhang YS, Zhong KL, Yuan Y, Zhang MW, Zhang Y, Mao N.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan 30; 20(1):79-82. PubMed ID: 15182628
    [Abstract] [Full Text] [Related]

  • 11. The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles.
    Fischer S, Uetz-von Allmen E, Waeckerle-Men Y, Groettrup M, Merkle HP, Gander B.
    Biomaterials; 2007 Feb 30; 28(6):994-1004. PubMed ID: 17118442
    [Abstract] [Full Text] [Related]

  • 12. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.
    He X, Jiang L, Wang F, Xiao Z, Li J, Liu LS, Li D, Ren D, Jin X, Li K, He Y, Shi K, Guo Y, Zhang Y, Sun S.
    J Control Release; 2005 Oct 03; 107(2):357-72. PubMed ID: 16099068
    [Abstract] [Full Text] [Related]

  • 13. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.
    Spellerberg MB, Zhu D, Thompsett A, King CA, Hamblin TJ, Stevenson FK.
    J Immunol; 1997 Aug 15; 159(4):1885-92. PubMed ID: 9257853
    [Abstract] [Full Text] [Related]

  • 14. [The experimental study on idiotypic DNA vaccine against human B-cell lymphoma to induce antitumor immune response].
    Zhong KL, Zhang WJ, Yuan Y, Wu Y, Zhang MW, Mao N.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec 15; 11(6):609-15. PubMed ID: 14706145
    [Abstract] [Full Text] [Related]

  • 15. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses.
    Thomas C, Gupta V, Ahsan F.
    Int J Pharm; 2009 Sep 08; 379(1):41-50. PubMed ID: 19524654
    [Abstract] [Full Text] [Related]

  • 16. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
    Kazzaz J, Singh M, Ugozzoli M, Chesko J, Soenawan E, O'Hagan DT.
    J Control Release; 2006 Feb 21; 110(3):566-73. PubMed ID: 16360956
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM, Singh G, Hermanson G, Hobart P, Czerwinski DK, Taidi B, Rajapaksa R, Caspar CB, Van Beckhoven A, Levy R.
    Cancer Res; 2002 Oct 15; 62(20):5845-52. PubMed ID: 12384547
    [Abstract] [Full Text] [Related]

  • 18. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
    Wang D, Molavi O, Lutsiak ME, Elamanchili P, Kwon GS, Samuel J.
    J Pharm Pharm Sci; 2007 Oct 15; 10(2):217-30. PubMed ID: 17706180
    [Abstract] [Full Text] [Related]

  • 19. Development of new polymer-based particulate systems for anti-glioma vaccination.
    Sapin A, Garcion E, Clavreul A, Lagarce F, Benoit JP, Menei P.
    Int J Pharm; 2006 Feb 17; 309(1-2):1-5. PubMed ID: 16386390
    [Abstract] [Full Text] [Related]

  • 20. Microparticles for the delivery of DNA vaccines.
    O'Hagan DT, Singh M, Ulmer JB.
    Immunol Rev; 2004 Jun 17; 199():191-200. PubMed ID: 15233735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.